Oura prepares for a September IPO that could value the wearable health tracker maker at over $16 billion
Executive summary: Oura is reportedly considering a September 2026 IPO with a target valuation above $16 billion. Such a valuation would set a new benchmark for wearable health‑technology listings and could boost investor appetite for similar IPOs in the sector.
Who is involved: Oura (health‑tech company), potential underwriters and investors, and the U.S. Securities and Exchange Commission (for future filing).
Likely next: Formal SEC registration statement filing, followed by a roadshow and pricing ahead of a anticipated September 2026 listing.
TechCrunch reports that Oura is exploring a September 2026 initial public offering with a potential valuation exceeding $16 billion. The figure highlights strong investor enthusiasm for consumer health‑tech devices and would place the company among the most highly valued wearables‑focused IPOs in recent years. While the timeline remains provisional, the move signals confidence in the sector’s growth prospects despite broader market volatility.
Timeline
- — Oura is reportedly eyeing a September IPO that could value it at more than $16B (TechCrunch)
Analysis — what this means
Likely next events
- Oura reportedly considering IPO in September 2026
- Potential valuation exceeding $16 billion
Sectors affected
- Wearable health technology
- Consumer electronics
- Digital health
Regulatory implications
- Must file a registration statement with the U.S. Securities and Exchange Commission
- Subject to SEC review and possible comments before effectiveness
Historical parallels
- Fitbit’s 2015 IPO valued at approximately $4.1 billion
- Garmin’s 2006 IPO valued at around $1.9 billion